Trials / Completed
CompletedNCT05074043
COVID-19 Associated Mucormycosis: A Multidisciplinary Dilemma in Assiut University Hospital
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 433 (actual)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
We aimed to describe the frequency; presentations, predictors, in-hospital outcome of mucormycosis patients in the scope of COVID-19. All patients with COVID-19 associated Mucormycosis (CAM) admitted to Assuit University Hospital between March 1, 2021, and July 30, 2021, were included in this study. The patient characteristics, the site of mucormycosis, the comorbidities, the steroids usage, and the outcome were analyzed in people with COVID-19.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | antiviral, surgical | surgical debridment |
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2021-06-30
- Completion
- 2021-07-30
- First posted
- 2021-10-12
- Last updated
- 2021-10-12
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05074043. Inclusion in this directory is not an endorsement.